Table 2.
FAs and their derivatives as PPARs ligands.
| Receptor | PPARα | PPARβ/δ | PPARγ |
|---|---|---|---|
| Ligands | Saturated FAs (weaker) | Unsaturated FAs | Unsaturated FAs (LA, LNA, CLA, DHA, EPA) |
| Unsaturated FAs (LA, LNA, PUFAs, including AA, EPA, phytanic acid) | Saturated FAs (much weaker) Prostacyclin |
15-d-PGJ2 15-HETE |
|
| Leukotriene B4 | 4-HNE | 9-HODE | |
| 8-HETE | 4-HDDE | 13-HODE | |
| 8,9-Epoxyeicosatrienoic acids | |||
| 11,12-Epoxyeicosatrienoic acids | |||
| OEA | |||
| PEA |
AA, arachidonic acid; CLA, conjugated linoleic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; 15-d-PGJ2, 15-deoxy-Δ12,14 prostaglandin J2; LA, linoleic acid; LNA, α-linolenic acid; OEA, oleoylethanolamide; PEA, palmitoylethanolamide; 4-HDDE, 4-hydroxydodeca-(2E,6Z)-dienal; 4-HNE, 4-hydroxy-2-nonenal; 15-HETE, 15(S)-hydroxyeicosatetraenoic acid; HODE, hydroxyoctadecadienoic acid.